top of page
Boston Medical Center

What's New?

Follow us @SyndemicsLab

Funders & Collaborators

NIDA_edited_edited.jpg
723px-US_CDC_logo_edited.png
CFAR_formal_logo.png
pp2020-08-04_CHERISH LOGO_MAP_edited.png

Recent Publications

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

The association between naloxone claims and proportion of independent vs. chain pharmacies: A longitudinal analysis of naloxone claims in the US

Christina E. Freibott, Ali Jalali, Sean M. Murphy, Alexander Y. Walley, Benjamin P Linas, Philip J Jeng, Jeffrey Bratberg, Brandon D.L. Marshall, Xiao Zang, Traci C Green, Jake R. Morgan

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts

Avik Chatterjee, Michelle Weitz, Alexandra Savinkina, Alexandria Macmadu, R. W. M. A. Madushani, Ruth A. Potee, Danielle Ryan, Sean M. Murphy, Alexander Y. Walley, Benjamin P. Linas,

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder

Tabatabaeepour N, Morgan JR, Jalali A, Kapadia SN, Meinhofer A

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus

Rachel L Epstein, Benjamin Buzzee, Laura F. White, Jordan J, Feld, Laurant Castera, Richard K. Sterling, Benjamin P. Linas, Lynn E. Taylor

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

Estimating Absenteeism Related to Nonalcohol Substance Use in a US National Cohort of Full-Time Employees

Morgan JR, Murphy SM, Assoumou SA, Linas BP

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder

Morgan JR, Quinn EK, Chaisson CE, Ciemins E, Stempniewicz N, White LF, Larochelle MR

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder

Juliet M. Flam-Ross, Elizabeth Marsh, Michelle Weitz, Alexandra Savinkina, Bruce R. Schackman, Jianing Wang, R. W. M. Madushani, Jake R. Morgan, Joshua A. Barocas, Alexander Y. Walley, Stavroula A. Chrysanthopoulou, Benjamin P. Linas, Sabrina A. Assoumou

HIV, PrEP, Buprenorphine, Naloxone, Opioid Epidemic,
Read More

Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured

Epstein RL, Wang J, White LF, Kapadia SN, Morgan JR, Bao Y, Linas BP

bottom of page